Anaplan

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. Allogene Therapeutics, Inc. (ALLO) will issue 16 million shares between $16 and $18 Thursday on the Nasdaq. With a portfolio acquired from Pfizer Inc. (NYSE: PFE), the biotech firm develops allogeneic CAR-T therapies...

It's not uncommon for startups to brag about raising $100 million. In January, View (a startup that builds glass windows that can react to external conditions) announced that it had raised $100 million -- all from one investor. In March, Actifio (which focuses on data storage and data...